Total Payments
$1,656
2024 Payments
$48.39
Companies
16
Transactions
80
Medicare Patients
31
Medicare Billing
$2,648
Payment Breakdown by Category
Food & Beverage$1,656 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,656 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $305.99 | 13 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $299.79 | 13 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $229.69 | 14 | $0 (2021) |
| Alkermes, Inc. | $194.64 | 5 | $0 (2021) |
| ITI, Inc. | $166.86 | 7 | $0 (2021) |
| Eisai Inc. | $78.10 | 5 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $77.29 | 4 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.43 | 4 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $62.13 | 4 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $46.11 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.39 | 2 | ABBVIE INC. ($48.39) |
| 2023 | $185.55 | 6 | ABBVIE INC. ($185.55) |
| 2022 | $104.23 | 6 | ABBVIE INC. ($58.12) |
| 2021 | $859.50 | 36 | Neurocrine Biosciences, Inc. ($212.51) |
| 2020 | $318.29 | 20 | Otsuka America Pharmaceutical, Inc. ($85.22) |
| 2019 | $139.90 | 10 | Neurocrine Biosciences, Inc. ($44.98) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 03/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Central Nervous System | ||||||
| 06/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Central Nervous System | ||||||
| 12/14/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 09/07/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $56.75 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEUROLOGY | ||||||
| 09/02/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $99.10 | General |
| Category: NEUROLOGY | ||||||
| 07/23/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/14/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROLOGY | ||||||
| 07/07/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: PSYCHIATRY | ||||||
| 06/30/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | KAPSPARGO (Drug), EZALLOR SPRINKLE, DRIZALMA SPRINKLE | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiology Vascular Diseases | ||||||
| 06/17/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: PSYCHIATRY | ||||||
| 06/16/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 31 | 78 | $4,716 | $2,648 |
Total Patients
31
Total Services
78
Medicare Billing
$2,648
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 19 | 66 | $3,564 | $1,983 | 55.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 12 | $1,152 | $665.04 | 57.7% |
About Dr. Tracy Epperson, MD
Dr. Tracy Epperson, MD is a Case Manager/Care Coordinator healthcare provider based in La Grande, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841498987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tracy Epperson, MD has received a total of $1,656 in payments from pharmaceutical and medical device companies, with $48.39 received in 2024. These payments were reported across 80 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,656).
As a Medicare-enrolled provider, Epperson has provided services to 31 Medicare beneficiaries, totaling 78 services with total Medicare billing of $2,648. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Case Manager/Care Coordinator
- Other Specialties Psychiatry, Student in an Organized Health Care Education/Training Program
- Location La Grande, OR
- Active Since 07/10/2007
- Last Updated 02/09/2024
- Taxonomy Code 171M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841498987
Products in Payments
- INGREZZA (Drug) $299.79
- VRAYLAR (Drug) $278.05
- CAPLYTA (Drug) $166.86
- REXULTI (Drug) $131.88
- LYBALVI (Drug) $125.00
- ABILIFY MAINTENA (Drug) $113.74
- TRINTELLIX (Drug) $95.65
- Dayvigo (Drug) $78.10
- KAPSPARGO (Drug) $77.29
- ARISTADA (Drug) $69.64
- AUSTEDO (Drug) $46.11
- HETLIOZ (Drug) $44.27
- SUNOSI (Drug) $25.71
- FANAPT (Drug) $17.86
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $15.71
- ZEPOSIA (Drug) $14.85
- VYVANSE (Drug) $14.41
- INVEGA SUSTENNA (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.